VIRUS-HOST INTERACTIONS WITH HUMAN T-CELL LEUKEMIA VIRUS TYPE I NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


VIRUS-HOST INTERACTIONS WITH HUMAN T-CELL LEUKEMIA VIRUS TYPE I

Diss Abstr Int (Sci); 47(6):2303 1986. Unique Identifier : AIDSLINE ICDB/87638367
Kanner SB; University of Miami


Abstract: Human T-cell leukemia virus type I (HTLV-I) has been associated with the etiology of adult T-cell leukemia/lymphoma (ATL), an aggressive mature T-cell proliferative disorder. Antiviral antibodies with specificity for both structural and non-structural HTLV-I polypeptides were detected previously in sera of ATL patients (pts) and in sera of some of the pts' family members. In Miami, an endemic focus of HTLV-I was found in the Haitian population. HTLV-I infections did not obviously coincide with disease in these individuals. Antibodies to bacterially expressed peptides of the env antigens gp46 and p21E were detected by immunoblot analysis in seropositive individuals. Anti-p21E titers ranged from 80 to 50,000 among infected individuals. Immunoglobulin levels to the major core polypeptide p24 were quantitated by radioimmunoassay in liquid, and ranged in titer from 80 to 50,000. A high degree of correlation was found between antibody levels to p21E and p24, and was consistent over a wide range of titers. Antibody titers to p21E and p24 were invariant among 13 out of 13 seropositive individuals followed longitudinally for 3 yr. The invariability of these antibody titers suggested that the virus-host interactions were stable. Virus was isolated from the peripheral blood lymphocytes of seropositive individuals, and was persistent in 7 of 7 virus positive individuals. Viral polypeptide p24 was detected in cultured lymphocytes stimulated to divide by phytohemagglutinin and maintained in interleukin-2. Intracellular levels of p24, 375-650 ng p24 per mg cellular protein, correlated with extracellular release of p24 in virus particles in the culture media. A high degree of correlation between the level of antiviral antibody and the ability to isolate virus in peripheral blood lymphocytes was found in 13 seropositive adults. However, antibody levels to p24 and p21E correlated with infection but not with disease. Antibodies to two specific p24 polypeptide epitopes persisted, but varied in titer among infected individuals, and did not correlate with virus persistence or with disease. Virus-host interactions were demonstrated in steady-state HTLV-I infections by serologic and virologic parameters.
Keywords: Antibodies, Viral/*ANALYSIS Antibody Specificity Antigenic Determinants/IMMUNOLOGY Human HTLV-BLV Infections/*IMMUNOLOGY HTLV-BLV Viruses/*IMMUNOLOGY Retroviridae Proteins/IMMUNOLOGY THESIS

KWDantibodies,viral/KWDanalysisantibodyspecificityantigenicdeterminants/immunologyhumanhtlv-blvinfections/KWDimmunologyhtlv-blvviruses/KWDimmunologyretroviridaeproteins/immunologythesis
871230
M87C0385


Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .